<img src="https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2?size=2" nborder="0" align="left" hspace="5" vspace="5" title="sns insider pvt ltd.png" alt="SNS Insider pvt ltd"/>U.S. Renal Denervation Devices Market to Reach USD 2.01 Billion and Europe USD 1.13 Billion by 2035 as Ultrasound Catheters, CMS Coverage Review, and Expanding Indications Drive Growth.Austin, United States, Sept. 14, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- Renal Denervation Devices Market Size &amp; Growth Analysis: According to SNS Insider, The <a href="https://www.globenewswire.com/Tracker?data=1DMzCvaAjpCRhGo6d_LFFUOaB6syg7nzPPWeEQYf5wDxRJfkYw0uFJJ2kHvk9vn3drQ1BC8O4D7juG_mDvXw82YC7n8_9h_nRbtqefqyz58LHmFF4BLAE9w7WeH6wquRsDxckQqzBifa-q_XvS7nJkZY436kxC9tic-j4BjABX8LmBedqyBRu4SGcxJhcVxA" rel="nofollow" target="_blank" title="Renal Denervation Devices Market">Renal Denervation Devices Market</a> was valued at USD 972.60 Million in 2025 and is projected to reach USD 4,840.60 Million by 2035, registering a CAGR of 17.4% from 2026 to 2035. Market forces driving changes to treatment of resistant and uncontrolled hypertension are based on the development of an alternative method to medication that uses minimally invasive procedures employing a catheter. Growth in the category comes from global increase in the prevalence of hypertension, growing physician acceptance due to pivotal trials conducted in a controlled group with a placebo procedure, FDA/CE approvals, and increased application of technologies such as radiofrequency, ultrasound, and chemical ablation. Development of multi-electrode catheters, AI-assisted procedural navigation, and expansion of clinical indications from resistant hypertension into chronic kidney disease and heart failure continue to shape the competitive and clinical trajectory of the category. <img alt="Renal Denervation Devices Market Growth" height="400" src="https://ml.globenewswire.com/Resource/Download/175b97ed-b863-4a2f-88d6-e48a8c116a89/renal-denervation-devices-market.jpg" width="600" data-dpi="96" data-filename="Renal-Denervation-Devices-Market.jpg" /> Download the Renal Denervation Devices Market Sample Report: <a href="https://www.globenewswire.com/Tracker?data=3K9PGXhbHlZfGcmMRzA7-NE5DYZvn5_Qr834tJLg5XK-qBoCSfavkCheTDAdPzcNWWsDntEZRViZ5ChBbjxkVmxBreX7OpMkZOpf_hlhRaobpJ1W_7CBGEycye98Dz8mQcgp2ArWzYIyT9f8qDb6h0-nEy7bpKxE5LorHkPIwKE=" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/sample-request/10843</a> Renal Denervation Devices Market Key Highlights <ul><li style="margin-top:0cm; margin-bottom:6pt;">Market size, 2025: USD 972.60 Million</li><li style="margin-top:0cm; margin-bottom:6pt;">Market forecast, 2035: USD 4,840.60 Million</li><li style="margin-top:0cm; margin-bottom:6pt;">CAGR: 17.4% from 2026 to 2035</li><li style="margin-top:0cm; margin-bottom:6pt;">Largest region: North America, approximately 52.60% share in 2025</li><li style="margin-top:0cm; margin-bottom:6pt;">Fastest-growing region: Asia Pacific, approximately 21.40% CAGR</li><li style="margin-top:0cm; margin-bottom:6pt;">Largest technology: Radiofrequency Renal Denervation Systems, approximately 61.40% share in 2025</li><li style="margin-top:0cm; margin-bottom:6pt;">Fastest-growing technology: Ultrasound Renal Denervation Systems, approximately 19.1% CAGR</li><li style="margin-top:0cm; margin-bottom:6pt;">Largest product type: Catheters, approximately 57.80% share in 2025</li><li style="margin-top:0cm; margin-bottom:6pt;">Fastest-growing product type: Generators/Energy Consoles, approximately 18.8% CAGR</li><li style="margin-top:0cm; margin-bottom:6pt;">Largest application: Resistant Hypertension, approximately 58.60% share in 2025</li><li style="margin-top:0cm; margin-bottom:6pt;">Fastest-growing application: Chronic Kidney Disease with Hypertension, approximately 19.3% CAGR</li><li style="margin-top:0cm; margin-bottom:6pt;">Largest end user: Hospitals, approximately 63.50% share in 2025</li><li style="margin-top:0cm; margin-bottom:6pt;">Fastest-growing end user: Cardiac Catheterization Laboratories, approximately 18.6% CAGR</li></ul> Market Relevance Renal denervation therapy has developed into a well-validated option of devices therapy in those patients who have uncontrolled blood pressure despite taking three or more anti-hypertensive drugs. Clinical data based on sham-controlled pivotal trials have been building the strength of physicians’ belief and treatment guidelines regarding this category of devices therapy. Renal Denervation Devices Market Overview There exist radiofrequency and ultrasound devices for renal denervation that incorporate catheters and energy consoles. The market serves to provide treatment to patients with resistant hypertension and chronic kidney diseases complicated by hypertension in hospitals and cardiac catheterization laboratories. Radiofrequency devices have the greatest validation due to more than a decade of usage and proven catheter technologies with several electrodes. Ultrasound devices gain greater popularity because of the circumferential delivery of energy from the balloon. Strategic Market Outlook The areas of opportunity include the expansion of indications from resistant hypertension to chronic kidney disease and heart failure as the trial data is being studied on the renoprotective and cardioprotective capabilities of the procedure. The rapid development of catheterization lab facilities in Asia Pacific, Latin America, and Middle East with the support of government-sponsored healthcare financing programs constitutes another area of opportunity for companies providing cost-effective radiofrequency options. Uncertainty in reimbursement and costliness of procedures are key challenges. There are still many healthcare systems which are reviewing or have not yet finalized their coverage policies for renal denervation procedures, which means that the adoption is currently limited to academic medical centers or well-funded hospitals. Also, there is a very significant upfront cost involved in buying single use catheters and generator/console for renal denervation procedures. Renal Denervation Devices Market Regional Analysis North America emerged as the leading region, holding around 52.60% of market share in 2025 due to well-established healthcare infrastructure, robust reimbursement policies, and fast adoption of advanced cardiovascular technology. The U.S. contributed significantly to the regional revenue generation due to its high prevalence rate of resistant hypertension patients, advanced interventional cardiology infrastructure, and CMS involvement to make Medicare available for renal denervation procedures across the nation. The U.S. Renal Denervation Devices Market was valued at approximately USD 424.60 Million in 2025 and is projected to reach approximately USD 2,007.00 Million by 2035, registering a CAGR of approximately 16.8% from 2026 to 2035. The Europe Renal Denervation Devices Market held approximately 25.00% of the global market in 2025, valued at USD 0.24 Billion, and is expected to reach USD 1.13 Billion by 2035, growing at a CAGR of 16.50% from 2026 to 2035. Growth is supported by early regulatory approval history and well-established public healthcare systems, with Germany accounting for approximately 22.80% of European revenue in 2025, driven by its dense concentration of interventional cardiology centers. The Asia-Pacific region is advancing at the fastest pace, growing at a CAGR of approximately 21.40% through 2035, driven by rapidly increasing hypertension prevalence and an expanding elderly population. China accounted for approximately 31.20% of regional revenue in 2025, supported by substantial government investment in hospital infrastructure and rapidly expanding interventional cardiology capacity. Middle East &amp; Africa: The UAE accounted for approximately 26.50% of regional revenue in 2025, supported by advanced private hospital infrastructure and substantial cardiovascular care investment. Latin America: Brazil accounted for approximately 34.60% of regional revenue in 2025, supported by growing public and private hospital cath lab investment. Buy the Renal Denervation Devices Market Report with Competitive Analysis and 2035 Forecast: <a href="https://www.globenewswire.com/Tracker?data=3K9PGXhbHlZfGcmMRzA7-NE5DYZvn5_Qr834tJLg5XJxEr6SudlRo8mUnKlhG-zIKYktdHXjy4Ij9KQ3PEOokuEXAQ7UjSriYXa6TdsZmUqYz5E21Y0hoYhLZH2qjVjSSLIy6sV9S7ri5vIkJuPurA==" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/checkout/10843</a> Renal Denervation Devices Market Segment Analysis By Technology: Radiofrequency Renal Denervation Systems were responsible for about 61.40% market share in 2025, backed by proven results from sham-controlled pivotal studies and early approvals in key regions. On the other hand, Ultrasound Renal Denervation Systems are expected to be the fastest growing segment at 19.1% CAGR due to the preference of physicians for operator-independent energy delivery. By Product Type: Catheters segment accounted for about 57.80% of the market in 2025 due to the fact that these devices are one time use only per procedure, and act as the key income generator of every ablation process. The generators/energy console is the fastest growing segment of about 18.8% CAGR. By Application: Resistant Hypertension held 58.60% market share in 2025 owing to being the original and most clinically proven application of renal denervation therapy. The most rapidly growing application is Chronic Kidney Disease with Hypertension due to emerging evidences of acceleration of decline in renal functions caused by hyperactivity of sympathetic nerves. By End User: In 2025, the hospitals market share was about 63.50%, considering the concentration of the interventional cardiology program and the team of hypertension specialists. Cardiac Catheterization Laboratories are growing the fastest, accounting for 18.6% CAGR, as they specialize in both structural heart intervention and renal denervation. Renal Denervation Devices Market Key Trends <ul><li style="margin-top:0cm; margin-bottom:6pt;">Rising adoption of ultrasound-based systems improving procedural consistency versus first-generation radiofrequency catheters</li><li style="margin-top:0cm; margin-bottom:6pt;">Growing integration of AI-assisted imaging and intravascular navigation improving catheter positioning accuracy</li><li style="margin-top:0cm; margin-bottom:6pt;">Expanding clinical evidence from sham-controlled pivotal trials strengthening physician confidence and guideline recommendations</li><li style="margin-top:0cm; margin-bottom:6pt;">Increasing development of multi-electrode catheter platforms enabling faster, more uniform nerve ablation</li><li style="margin-top:0cm; margin-bottom:6pt;">Rising expansion of indications into chronic kidney disease and heart failure broadening the addressable patient population</li></ul> Competitive Landscape The Renal Denervation Devices Market includes established cardiovascular device manufacturers and specialized ablation technology developers, with competition centred on catheter design, procedural efficiency, and clinical evidence generation. In 2026, Terumo remained among the leading companies advancing renal denervation technologies, with competition increasingly focused on catheter design and treatment safety. In 2025, the American College of Cardiology and the Smith Center launched a joint renal denervation registry module linking real-world outcomes data across the ACC CathPCI Registry to expand post-market clinical evidence. In 2024, Ablative Solutions advanced pivotal clinical development of its Peregrine System Infusion Catheter, a chemical renal denervation platform using targeted alcohol-mediated nerve ablation as an alternative to energy-based technologies. Major key players include <ul><li style="margin-top:0cm; margin-bottom:6pt;">Medtronic plc</li><li style="margin-top:0cm; margin-bottom:6pt;">ReCor Medical, Inc. (Otsuka Holdings Co., Ltd.)</li><li style="margin-top:0cm; margin-bottom:6pt;">Boston Scientific Corporation</li><li style="margin-top:0cm; margin-bottom:6pt;">Johnson &amp; Johnson MedTech</li><li style="margin-top:0cm; margin-bottom:6pt;">Abbott Laboratories</li><li style="margin-top:0cm; margin-bottom:6pt;">Terumo Corporation</li><li style="margin-top:0cm; margin-bottom:6pt;">Cordis</li><li style="margin-top:0cm; margin-bottom:6pt;">B. Braun Melsungen AG</li><li style="margin-top:0cm; margin-bottom:6pt;">Biotronik SE &amp; Co. KG</li><li style="margin-top:0cm; margin-bottom:6pt;">Ablative Solutions, Inc.</li><li style="margin-top:0cm; margin-bottom:6pt;">MicroPort Scientific Corporation</li><li style="margin-top:0cm; margin-bottom:6pt;">Mercator MedSystems, Inc.</li><li style="margin-top:0cm; margin-bottom:6pt;">Symple Surgical, Inc.</li><li style="margin-top:0cm; margin-bottom:6pt;">AngioDynamics, Inc.</li><li style="margin-top:0cm; margin-bottom:6pt;">Lepu Medical Technology Co., Ltd.</li><li style="margin-top:0cm; margin-bottom:6pt;">Balton Sp. z o.o.</li><li style="margin-top:0cm; margin-bottom:6pt;">Acotec Scientific Holdings Limited</li><li style="margin-top:0cm; margin-bottom:6pt;">Merit Medical Systems, Inc.</li><li style="margin-top:0cm; margin-bottom:6pt;">Cook Medical</li><li style="margin-top:0cm; margin-bottom:6pt;">SoniVie Ltd.</li></ul> Explore the Complete Renal Denervation Devices Market Report: <a href="https://www.globenewswire.com/Tracker?data=3K9PGXhbHlZfGcmMRzA7-NE5DYZvn5_Qr834tJLg5XL2YjABfBJ3MW1YD-2livz97lAIfHH0tb2ur2NiNioDJbT3QJdQP_zaxLQHB4VTupmJR7KDXw8QRXJcD0Dc2emhbtIJYdslnwbolQVMbdsEmYlCyd1CwYR0fbONQuYqUfNI_RqoiiXRXO122Z4XowyX8BvozFcYIHyKxA7rA0k26IGNyICKIfHrwl_lWh3Bcn0=" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/reports/renal-denervation-devices-market-10843</a> <pre>CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com
</pre> <img alt="" src='https://ml.globenewswire.com/media/YTBjYjhkZWMtZTE1Ny00OWY0LWI2MzItNDU2YzhiOTIzMzhhLTEyNjg4MTktMjAyNi0wOS0xNC1lbg==/tiny/SNS-Insider-pvt-ltd.png' referrerpolicy='no-referrer-when-downgrade' />

Renal Denervation Devices Market Size to Reach USD 4.84 Billion by 2035, Growing at a CAGR of 17.4% - SNS Insider

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn